Phage display-derived cross-reactive neutralizing antibody against enterovirus 71 and coxsackievirus A16

xiao zhang,chunyun sun,xiangqian xiao,lin pang,sisi shen,jie zhang,shan cen,burton b yang,yuming huang,wang sheng,yi zeng

DOI: https://doi.org/10.7883/yoken.JJID.2015.060

2016-01-01

Japanese Journal of Infectious Diseases

Abstract:Enterovirus 71 (EV71) and coxsackievirus A16 (CVA16) are members of the Picornaviridae family and are considered the main causative agents of hand, foot and mouth disease (HFMD). In recent decades large HFMD outbreaks caused by EV71 and CVA16 have become significant public health concerns in the Asia-Pacific region. Vaccines and antiviral drugs are unavailable to prevent EV71 and CVA16 infection. In the current study, a chimeric antibody targeting a highly conserved peptide in the EV71 VP4 protein was isolated by using a phage display technique. The antibody showed cross neutralizing capability against EV71 and CVA16 in vitro. The results suggest that this phage display derived antibody will have great potential as a broad neutralizing antibody against EV71 and CVA16 after affinity maturation and humanization.